Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver

Journal of Hepatology

Volumn 48, Issue 2, 2008, Pages 266-275

  Poyck, Paul P C ^a   van Wijk, Albert C W A ^a   van der Hoeven, Tessa V ^a   de Waart, Dirk R ^a   Chamuleau, Robert A F M ^a   van Gulik, Thomas M ^a   Oude Elferink, Ronald P J ^a   Hoekstra, Ruurdtje ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute liver failure; AMC BAL; Ammonia; Artificial liver; cBAL111; Glutamine synthetase; Liver cell line; Stem cell

Indexed keywords

ALBUMIN; AMMONIA; GALACTOSE; GLUTAMATE AMMONIA LIGASE; GLUTAMINE; LIDOCAINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BIOARTIFICIAL LIVER; BIOREACTOR; CELL CULTURE; CELL FUNCTION; CELL IMMORTALIZATION; CELL METABOLISM; CONTROLLED STUDY; FETUS; FETUS LIVER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; UREA CYCLE;

AMINO ACIDS; AMMONIA; BIOREACTORS; CARBOHYDRATE METABOLISM; CELL LINE; DNA; FETUS; HUMANS; LIVER; LIVER, ARTIFICIAL; OXYGEN CONSUMPTION;

EID: 38049047729     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.09.018     Document Type: Article

References (30)

1. Hoekstra R., and Chamuleau R.A. Recent developments on human cell lines for the bioartificial liver. Int J Artif Organs 25 (2002) 182-191
2. Deurholt T, van Til NP, Chhatta AA, Ten Bloemendaal L, Schwartlander R, Payne C, et al. Novel immortalized human fetal liver cell line, cBAL111, has the potential to fully differentiate into functional Hepatocytes, submitted for publication.
3. Flendrig L.M., La Soe J., Jorning G.G., Steenbeek A., Karlsen O.T., Bovee W.M., et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 26 (1997) 1379-1392
4. Flendrig L.M., Chamuleau R.A., Maas M.A., Daalhuisen J., Hasset B., Kilty C.G., et al. Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. J Hepatol 30 (1999) 311-320
5. Deurholt T., Ten Bloemendaal L., Chatta A.A., van Wijk A.C., Weijer K., Seppen J., et al. In vitro functionality of human fetal liver cells and clonal derivatives under proliferative conditions. Cell Transplant 15 (2006) 811-822
6. van de Kerkhove M.P., Poyck P.P., van Wijk A.C., Galavotti D., Hoekstra R., van Gulik T.M., et al. Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs 28 (2005) 617-630
7. Poyck PP, Hoekstra R, Vermeulen JL, van Wijk AC, Chamuleau RA, Hakvoort TB, et al. Expression of glutamine synthetase and carbamoylphosphate synthetase I in a bioartificial liver: markers for the development of zonation in vitro, Cells Tissues Organs, in press.
8. van Eijk H.M., van der Heijden M.A., van Berlo C.L., and Soeters P.B. Fully automated liquid-chromatographic determination of amino acids. Clin Chem 34 (1988) 2510-2513
9. Hoekstra R., Deurholt T., Poyck P.P., Bloemendaal L.T., and Chhatta A.A. Increased reproducibility of quantitative reverse transcriptase-PCR. Anal Biochem 340 (2005) 376-379
10. Poyck P.P., Hoekstra R., Chhatta A.A., Ten Bloemendaal L., van Wijk A.C., Galavotti D., et al. Time-related analysis of metabolic liver functions, cellular morphology and gene expression of hepatocytes cultured in a bioartificial liver. Tissue Eng 13 (2007) 1235-1246
11. Poyck P.P., Hoekstra R., van Wijk A.C., Attanasio C., Calise F., Chamuleau R.A., et al. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver. Liver Transplant 13 (2007) 589-598
12. Costa R.H., Kalinichenko V.V., Holterman A.X., and Wang X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 38 (2003) 1331-1347
13. Mavri-Damelin D., Eaton S., Damelin L.H., Rees M., Hodgson H.J., and Selden C. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2. Int J Biochem Cell Biol 39 (2007) 555-564
14. Enosawa S., Suzuki S., Kakefuda T., and Amemiya H. Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines. Cell Transplant 5 (1996) S39-S40
15. Wang L., Sun J., Li L., Mears D., Horvat M., and Sheil A.G. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. Cell Transplant 7 (1998) 459-468
16. Hongo T., Kajikawa M., Ishida S., Ozawa S., Ohno Y., Sawada J., et al. Three-dimensional high-density culture of HepG2 cells in a 5-ml radial-flow bioreactor for construction of artificial liver. J Biosci Bioeng 99 (2005) 237-244
17. Choi Y.S., Lee D.Y., Kim I.Y., Kang S., Ahn K., Kim H.J., et al. Ammonia removal using hepatoma cells in mammalian cell cultures. Biotechnol Prog 16 (2000) 760-768
18. Takagi M., Fukuda N., and Yoshida T. Comparison of different hepatocyte cell lines for use in a hybrid artificial liver model. Cytotechnology 24 (1997) 39-45
19. Odom D.T., Zizlsperger N., Gordon D.B., Bell G.W., Rinaldi N.J., Murray H.L., et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303 (2004) 1378-1381
20. Kyrmizi I., Hatzis P., Katrakili N., Tronche F., Gonzalez F.J., and Talianidis I. Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev 20 (2006) 2293-2305
21. Clotman F., Lannoy V.J., Reber M., Cereghini S., Cassiman D., Jacquemin P., et al. The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 129 (2002) 1819-1828
22. Tirona R.G., Leake B.F., Wolkoff A.W., and Kim R.B. Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther 304 (2003) 223-228
23. Kodama S., Koike C., Negishi M., and Yamamoto Y. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol Cell Biol 24 (2004) 7931-7940
24. Khalil M., Shariat-Panahi A., Tootle R., Ryder T., McCloskey P., Roberts E., et al. Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J Hepatol 34 (2001) 68-77
25. Selden C., Shariat A., McCloskey P., Ryder T., Roberts E., and Hodgson H. Three-dimensional in vitro cell culture leads to a marked upregulation of cell function in human hepatocyte cell lines - an important tool for the development of a bioartificial liver machine. Ann NY Acad Sci 875 (1999) 353-363
26. Selden C., Khalil M., and Hodgson H. Three dimensional culture upregulates extracellular matrix protein expression in human liver cell lines - a step towards mimicking the liver in vivo?. Int J Artif Organs 23 (2000) 774-781
27. Nyberg S.L., Remmel R.P., Mann H.J., Peshwa M.V., Hu W.S., and Cerra F.B. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg 220 (1994) 59-67
28. Liu J.J., Chen B.S., Tsai T.F., Wu Y.J., Pang V.F., Hsieh A., et al. Long term and large-scale cultivation of human hepatoma Hep G2 cells in hollow fiber bioreactor. Cultivation of human hepatoma Hep G2 in hollow fiber bioreactor. Cytotechnology 5 (1991) 129-139
29. van de Kerkhove M.P., Poyck P.P., van Wijk A.C., Galavotti D., Hoekstra R., van Gulik T.M., et al. Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs 28 (2005) 617-630
30. Mareels G., Poyck P.P., Eloot S., Chamuleau R.A., and Verdonck P.R. Three-dimensional numerical modeling and computational fluid dynamics simulations to analyze and improve oxygen availability in the AMC bioartificial liver. Ann Biomed Eng 34 (2006) 1729-1744